VIVA CAR T Patient Education Webinar
VIVA患者和护理者教育线上研讨会
急性淋巴细胞白血病的嵌合抗原受体T细胞疗法的实际考虑
星期五 9月02日 & 9月16日 | 18:00 - 19:00 (UTC+8) | 检查您的时区
再次收看
有关CAR-T患者支持的更多信息，请前往
https://www.mytcelltherapies.com/
讲者
唐沛容 医生
香港儿童医院
Dr TONG Pui Yung Grace studied medicine at the University of Hong Kong with HKU Foundation Entrance Scholarship. After graduation, she received six years of paediatric training in Queen Elizabeth Hospital and became a fellow of the Hong Kong College of Paediatricians. Throughout these years, she has developed interest and passion in paediatric haematology and oncology. She is now a resident specialist in the haematology and oncology unit of the Hong Kong Children’s Hospital.
李沅錞 药剂师
香港儿童医院临床药剂师
香港中文大学临床药剂学硕士
李沅錞药剂师于香港中文大学药剂学系一级荣誉毕业，是一名香港注册药剂师。她亦取得香港中文大学临床药剂学硕士学位。她目前在香港儿童医院担任临床药剂师，在儿童肿瘤科及造血干细胞移植中心提供临床药剂服务。她主力负责嵌合抗原受体T细胞疗法的药物采购以及相关的药物使用。
江颖思 资深护师
香港大學護理學士
香港大學護理學碩士
註冊護士
香港兒童醫院資深護師
於香港大學護理學畢業後，在瑪麗醫院兒童癌症及血病中心工作，為患有癌症及血病或接受幹細胞移植療程的兒童提供護理需要，其後轉職於香港兒童醫院血液及腫瘤中心工作。現主要為在造血幹細胞移植中心內接受治療的孩童提供護理。除日常護理外，亦會協助採集血液細胞整個程序及相關工作。
麦淑茵 资深护师
香港大學護理學學士
香港大學護理學碩士
註冊護士
香港兒童醫院資深護師
麥淑茵以一級榮譽畢業於香港大學護理學學系，就學期間曾獲多項獎學金包括「劉永佳獎學金」，擁有香港大學護理學學士以及護理學碩士學位。自 2014 年起加入瑪麗醫院兒童癌症及血病中心任職註冊護士, 從事此方面的臨床工作至今。她現任於香港兒童醫院造血幹細胞移植團隊資深護師，主力負責照顧移植病童及支援家屬，並參與協調嵌合抗原受體T細胞療法的護理工作。
主持
梁永恆 医生
临床教授
香港大学李嘉诚医学院
Professor Wing Leung, MBBS PhD, is the Head of the Department of Paediatrics and Adolescent Medicine at the University of Hong Kong. Previously, he was a faculty member at the Johns Hopkins University, University of Tennessee, and Duke-National University of Singapore. He was the Chair of Department of Bone Marrow Transplantation and Cellular Therapy at St. Jude Children’s Research Hospital, Senior Consultant in Hematology and Oncology at KK Women’s and Children’s Hospital, and Vice President of Clinical Development at Miltenyi Biotec and Biomedicine. Prof. Leung is a diplomate certified in general pediatrics and in pediatric hematology-oncology by the American Board of Pediatrics. He has a major research interest in the biology of human natural killer cells and memory T cells, specifically the clinical applications in hematopoietic stem cell transplantation and cellular therapy. His research received continuous funding from the National Institutes of Health. He is an elected Member of the American Society for Clinical Investigation.